A randomized, open-label, 2 way crossover study to assess the reciprocal effects of co-administration of rosuvastatin 40 mg and ezetimibe 10 mg on the steady-state pharmacokinetics of each drug
Study identifier:4522IL/0108
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Other
Official Title
A randomized, open-label, 2 way crossover study to assess the reciprocal effects of co-administration of rosuvastatin 40 mg and ezetimibe 10 mg on the steady-state pharmacokinetics of each drug
Medical condition
hypercholesterolaemia
Phase
N/A
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Jan 1971
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
-
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
